BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22729026)

  • 21. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
    Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy.
    Videla CO
    Transplant Proc; 2009; 41(6):2659-63. PubMed ID: 19715995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conversion from cyclosporine to tacrolimus in pediatric kidney transplant recipients.
    Ferraresso M; Ghio L; Edefonti A; Garavaglia R; Berardinelli L
    Pediatr Nephrol; 2002 Aug; 17(8):664-7. PubMed ID: 12185478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired erythropoietin production in liver transplant recipients: the role of calcineurin inhibitors.
    Bardet V; Junior AP; Coste J; Lecoq-Lafon C; Chouzenoux S; Bernard D; Soubrane O; Lacombe C; Calmus Y; Conti F
    Liver Transpl; 2006 Nov; 12(11):1649-54. PubMed ID: 17058250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria.
    Marsland AM; Soundararajan S; Joseph K; Kaplan AP
    Clin Exp Allergy; 2005 May; 35(5):554-9. PubMed ID: 15898974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of chronic urticaria in children with antihistamines and cyclosporine.
    Neverman L; Weinberger M
    J Allergy Clin Immunol Pract; 2014; 2(4):434-8. PubMed ID: 25017532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcineurin inhibitors in heart transplantation.
    Crespo-Leiro MG
    Transplant Proc; 2005 Nov; 37(9):4018-20. PubMed ID: 16386614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
    Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
    Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients.
    Koefoed-Nielsen PB; Karamperis N; Jørgensen KA
    Transplant Proc; 2005 May; 37(4):1736-8. PubMed ID: 15919449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience with cyclosporine in children with chronic idiopathic urticaria.
    Doshi DR; Weinberger MM
    Pediatr Dermatol; 2009; 26(4):409-13. PubMed ID: 19689515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statistical process control and calcineurin inhibitor management.
    Dunn SP
    J Pediatr; 2005 Jun; 146(6):720-1. PubMed ID: 15973304
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation.
    Di Gioacchino M; Di Stefano F; Cavallucci E; Verna N; Ramondo S; Paolini F; Caruso R; Schiavone C; Masci S; Santucci B; Paganelli R; Conti P
    Allergy Asthma Proc; 2003; 24(4):285-90. PubMed ID: 12974197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
    Sinha MD; MacLeod R; Rigby E; Clark AG
    Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients.
    Balfour IC; Srun SW; Wood EG; Belsha CW; Marshall DL; Ferdman BR
    J Heart Lung Transplant; 2006 May; 25(5):518-22. PubMed ID: 16678029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporine: advantages versus disadvantages vis-à-vis tacrolimus.
    Maes BD; Vanrenterghem YF
    Transplant Proc; 2004 Mar; 36(2 Suppl):40S-49S. PubMed ID: 15041305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic urticaria: pathogenesis and treatment.
    Kaplan AP
    J Allergy Clin Immunol; 2004 Sep; 114(3):465-74; quiz 475. PubMed ID: 15356542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suitable calcineurin inhibitor concentrations for liver transplant recipients in the Chinese population.
    Chen YB; Li SD; Ju BL; Shi XJ; Lu F; Hu DK; Yu CH; Dong JH
    Transplant Proc; 2011 Jun; 43(5):1751-3. PubMed ID: 21693271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.